Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kori Holman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 21, 2022
The efficacy and cost-impact of rasburicase 3 mg versus 6 mg for the management of tumor lysis syndrome: A multicenter analysisDennis Marjoncu, Kori Holman
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 8, 2025
The impact of bleomycin test doses on the development of acute hypersensitivity reactionsDennis Marjoncu, Kori Holman
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 8, 2023
Use of antithymocyte globulin (rabbit) in a patient with known alpha-gal syndrome undergoing allogenic stem cell transplantationHannah Peterson, Drew A Wells, Dennis Marjoncu, et al.
Pharmacotherapy|January 28, 2026
Cancer Therapy-Induced Cardiotoxicity: A Narrative ReviewDrew A Wells, Zachery Halford, Kori Holman, et al.
Clinical Lung Cancer|February 26, 2026
Outcomes of Concurrent Radiotherapy With Tarlatamab in Extensive-Stage Small Cell Lung Cancer From the DLL3 PanTUMOR DatabaseDiana Kim, Sarah Blocker, Courtney C Cavalieri, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2026
Risk factors for CRS and ICANS with tarlatamab in small cell lung cancer and associated efficacy outcomes: Insights from clinical practiceSarah Blocker, Diana Kim, Courtney C Cavalieri, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 21, 2022
The efficacy and cost-impact of rasburicase 3 mg versus 6 mg for the management of tumor lysis syndrome: A multicenter analysisDennis Marjoncu, Kori Holman
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 8, 2025
The impact of bleomycin test doses on the development of acute hypersensitivity reactionsDennis Marjoncu, Kori Holman
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 8, 2023
Use of antithymocyte globulin (rabbit) in a patient with known alpha-gal syndrome undergoing allogenic stem cell transplantationHannah Peterson, Drew A Wells, Dennis Marjoncu, et al.
Pharmacotherapy|January 28, 2026
Cancer Therapy-Induced Cardiotoxicity: A Narrative ReviewDrew A Wells, Zachery Halford, Kori Holman, et al.
Clinical Lung Cancer|February 26, 2026
Outcomes of Concurrent Radiotherapy With Tarlatamab in Extensive-Stage Small Cell Lung Cancer From the DLL3 PanTUMOR DatabaseDiana Kim, Sarah Blocker, Courtney C Cavalieri, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2026
Risk factors for CRS and ICANS with tarlatamab in small cell lung cancer and associated efficacy outcomes: Insights from clinical practiceSarah Blocker, Diana Kim, Courtney C Cavalieri, et al.
Pageof 1